We have fortuitously identified a nucleotide sequence that decreases expression of a reporter gene in the yeast Saccharomyces cerevisiae 20-fold when inserted into an intron. The primary effect of the insertion is a decrease in pre-mRNA abundance accompanied by the appearance of 3-truncated transcripts, consistent with premature transcriptional termination and/or pre-mRNA degradation. Point mutations in the cis element relieve the negative effect, demonstrating its sequence specificity. A novel yeast protein, named Nrd1, and a previously identified putative helicase, Sen1, help mediate the negative effect of the cis element. Sen1 is an essential nuclear protein that has been implicated in a variety of nuclear functions. Nrd1 has hallmarks of a heterogeneous nuclear ribonucleoprotein, including an RNA recognition motif, a region rich in RE and RS dipeptides, and a proline-and glutamine-rich domain. An N-terminal domain of Nrd1 may facilitate direct interaction with RNA polymerase II. Disruption of the NRD1 gene is lethal, yet C-terminal truncations that delete the RNA recognition motif and abrogate the negative effect of the cis element nevertheless support cell growth. Thus, expression of a gene containing the cis element could be regulated through modulation of the activity of Nrd1. The recent identification of Nrd1-related proteins in mammalian cells suggests that this potential regulatory pathway is widespread among eukaryotes.
A critical phase in the expression of a eukaryotic proteincoding gene occurs between the onset of synthesis of its premRNA transcript in the nucleus and the transport of the mature mRNA product to the cytoplasm. During this period, the 5Ј end of the nascent transcript acquires a 7-methylguanosine cap, the 3Ј end of the transcript is defined by endonucleolytic cleavage and addition of a polyadenylate tail, and introns are recognized and accurately excised (13, 44) . These processes are mediated by a remarkably complex machinery that is largely conserved from yeasts to vertebrates. Only after these processing steps are complete does mRNA normally become a substrate for transport through the nuclear pores and eventual translation (35) .
Despite the increasingly detailed picture of the mechanisms of the transcription and pre-mRNA processing reactions, many aspects of the nuclear metabolism of pre-mRNA and mRNA remain obscure. Mechanisms coordinating the various processing reactions, and the transport of mRNA from the sites of synthesis and processing to the nuclear pores, are only beginning to be elucidated (18, 56) . Proteins that associate with pre-mRNA as it is synthesized, known collectively as heterogeneous nuclear ribonucleoproteins (hnRNPs) (16) , presumably play a central role in directing these processes. For example, manipulation of the ratios of the hnRNP A1 protein and the splicing factor ASF/SF2 in vitro and in vivo can influence 5Ј splice site choice (9, 40, 61, 67) . Some hnRNPs, including A1, are thought to function in nucleocytoplasmic transport (41, 48) . hnRNP L can stimulate the maturation and cytoplasmic accumulation of intronless mRNAs containing appropriate sequence elements (38) . An additional role for hnRNPs in determining the stability of nuclear pre-mRNA seems plausible, although mechanisms for the nuclear turnover of pre-mRNA are not well defined. The lack of genetic approaches to the study of hnRNP function has hampered progress in understanding the roles of these proteins in vivo, but the recent identification of hnRNP proteins in Saccharomyces cerevisiae (3, 4, 39, 66) holds promise.
We have identified a sequence element that directs underexpression of a pre-mRNA, and consequently its mRNA and protein products, when inserted into an intron of a yeast reporter gene. The element is an artificial construct about 140 nucleotides (nt) long and includes antisense U6 spliceosomal RNA. Response to the cis element occurs after transcription initiation but before pre-mRNA splicing and results in the generation of truncated pre-mRNA fragments containing partial intron sequences, consistent with premature transcription termination and/or pre-mRNA degradation. A 20-fold decrease in the accumulation of pre-mRNA and mRNA is observed. Spontaneous point mutations arising within a 14-nt region of the antisense U6 sequence relieve the pre-mRNA accumulation defect but do not act by disrupting complementarity to U6 RNA. Rather, they may define a recognition site for a binding factor.
Mutations in a novel gene, which we have named NRD1 (for nuclear pre-mRNA down-regulation), and in the gene encoding Sen1 (15) , a putative ATP-dependent helicase, greatly diminish the cis-element-directed effect. The Nrd1 protein has several hnRNP-like features, including a single consensus RNA recognition motif (RRM), a short arginine-, serine-, and glutamate-rich segment similar to the regions rich in RE and RS dipeptides (RE/RS domains) found in many metazoan splicing factors, and a proline-and glutamine-rich C-terminal domain (PϩQ domain) similar to domains found in several yeast hnRNPs (66) . Disruption of NRD1 is lethal; however, analysis of several mutant alleles indicates that the RRM, RE/RS, and PϩQ domains are dispensable, and an N-terminal domain which may facilitate interactions with RNA polymer-ase II (68) is sufficient for viability. We propose that Nrd1 binds to cis-element-containing pre-mRNA as it is synthesized and that this is a key step in specifying the pre-mRNA for down-regulation. Modulation of Nrd1's activity may thus provide a mechanism for regulation of gene expression at the level of pre-mRNA accumulation.
MATERIALS AND METHODS
Yeast strains and methods. Yeast procedures were performed according to standard methods (25) . Copper plates were made and assays were performed as described previously (36, 37) . S. cerevisiae strain 46␣ (MAT␣ cup1⌬ ura3 his3 trp1 lys2 ade2 leu2) was obtained from C. Lesser . An isogenic MATa derivative of 46␣ was generated by introducing the HO endonuclease gene on a URA3-marked centromere plasmid (YCp50-HO) to induce mating type switching (25) . Transformants were then streaked on 5-fluoroorotic acid (5-FOA) plates to select for loss of the URA3-marked plasmid, and individual colonies were tested for the ability to mate with 46␣.
Plasmids were maintained in Escherichia coli DH5␣ and were transformed into S. cerevisiae by the lithium acetate procedure (55) . Plasmids were recovered from yeast cells by the method of Hoffman and Winston (28) . NRD1 and NRD2 were cloned from a yeast DNA library containing fragments from a partial Sau3A digest inserted in the BamHI site of YCp50 (52) . pRS316NRD1 has the HindIII fragment (see Fig. 6 ) inserted into the HindIII site of pRS316 (57) , which harbors the URA3 gene.
Mutant alleles of NRD1 and NRD2 were recovered on plasmids by gap repair (53) . The one-step gene disruption procedure (53) was used to create the heterozygous Nrd1 disruption strain EJS101. The disruption of NRD1 was created by inserting a 1.76-kb BamHI fragment containing the HIS3 gene between the BclI and BglII sites in the NRD1 gene of pRS316NRD1, yielding pRS316nrd1⌬::HIS3 (see Fig. 6 ). An EcoRV-SalI fragment containing the disruption construct was isolated and used to transform diploid strain EJS100. EJS100 was created by mating strains PJ43-2b (MAT␣ his3-11,15 leu2-3,112 trp1-1 ura3-52 met2-⌬1 lys2-⌬2 can1-100 ade2-1) and PJ51-3a, which has the same genotype as PJ43-2b except that it is MATa. PJ43-2b and PJ51-3a were obtained from Phil James (University of Wisconsin). Genomic DNA was isolated from several HIS ϩ transformants, digested with HindIII, and analyzed by Southern blotting to confirm the disruption of one copy of the genomic NRD1 locus.
ACT-CUP plasmid constructions. pGAC24, a LEU2-marked 2m plasmid containing the ACT-CUP fusion gene under the control of the GPD promoter and PGK terminator, was described previously (36) . Many of the ACT-CUP constructs described below were also moved into pRS426, a URA3-marked 2m plasmid (10) , by subcloning a 4.2-kb HindIII fragment that contained the LEU2 gene as well as the ACT-CUP gene from pGAC24 to create pRS426AC and derivatives.
The branch point consensus sequence mutation in which adenine is substituted for cytosine at position 256 of the intron (C256A) was created by site-directed mutagenesis (32) of a BamHI-SalI fragment containing the ACT-CUP coding region cloned into pRS313 (57). Standard cloning procedures were then used to recombine the branch point mutation with the U6 insertion constructs.
To introduce the U6 sequence into the XhoI site in the ACT1 intron in pGAC24, the transcribed portion of the yeast U6 gene (7) was amplified using the U6 5ЈAflIII and U6 3ЈBamHI oligonucleotide primers. The product was digested with BamHI and AflIII, incubated with E. coli DNA polymerase I Klenow fragment and deoxynucleoside triphosphates to fill in the sticky ends, and blunt-end ligated to XhoI-digested and Klenow-treated pGAC24. This yielded pGAC24-U6F, which contains the U6 sequence in the forward orientation, and pGAC24-U6R*, which contains the U6 sequence in the reverse orientation as well as 5Ј and 3Ј flanking sequences derived indirectly from the primer oligonucleotides. The sequence of the U6R* insert is as follows: ctcgaCATGTAGTTGCGACATGTAGTTGCGAGATCCGTAAAACGAA(94 nt) CTTCGCGAACATGTAGTTGCGAAAGGGTTACTTCGCGAACATGtcgaga gattt, where intron sequence is represented by lowercase letters, inserted sequence is represented by capital letters, and the antisense U6 sequence is represented by bold-faced type. NruI restriction sites are underlined, and AflIII sites are doubly underlined.
Deletion variants of the U6R* construct were created using pRS426AC-U6R* as the parent vector. pRS426AC-U6R*⌬Nru was created by digestion with NruI and religation, removing 30 nt of flanking sequence from the 3Ј end of the U6R* insertion. The resulting 3Ј junction sequence, CTTCGCGAACATGtcgaga (in which the antisense U6 sequence is in bold-faced capital letters, the recreated NruI site is underlined, and the intron sequence is in lowercase letters) is identical to that in the U6R construct (see below). U6R*⌬13 was created by deleting sequence between the two AflIII sites in the 5Ј flanking portion of U6R*⌬Nru. The R*⌬U6 construct was created by site-directed mutagenesis of the BamHI-SalI fragment of U6R*⌬Nru cloned into pRS313, and the mutated fragment was then subcloned back into pRS426AC or pGAC24. U6R*⌬NE was created by replacing a BamHI-NruI fragment of pRS426AC-U6R*⌬Nru with a BamHI-EcoNI fragment that had its EcoNI end filled in with Klenow fragment, thereby deleting 67 nt of antisense U6.
To generate pGAC24-U6R, which contains the U6 sequence in the reverse orientation but without the flanking sequences of U6R*, the U6 sequence was amplified with U6 5ЈXhoI and U6 3ЈXhoI primers, and the product was then digested with XhoI and ligated directly into pGAC24 digested with XhoI. A product of this ligation containing the U6 sequence in the reverse orientation was then digested with NruI, which cuts once in the vector upstream of the ACT-CUP gene and once at the 3Ј end of the U6R sequence. The resulting 1-kb fragment was then cloned into NruI-digested pGAC24-U6R* to generate pGAC24-U6R, in which the 5Ј end of antisense U6 directly abuts the intron XhoI site as follows: ttgctcgagAAAACGAAA (where the XhoI site is underlined and the antisense U6 sequence is in bold-faced capital letters). The sequence of U6R at the 3Ј antisense U6-intron junction is identical to that in the U6R*⌬Nru construct. Thus, U6R and U6R*⌬Nru differ only in the 33 nt of 5Ј flanking sequences present in the latter in place of the last G residue of the XhoI site.
Oligonucleotides. The oligonucleotides used in this study are as follows: U6 5ЈAflIII, 5Ј-TCGCAACTACATGTTCGCGAAGTAACCCTT; U6 3ЈBamHI, 5Ј-CGGGATCCGTAAAACGAAATAAATCTCTTTGT; U6 5ЈXhoI, 5Ј-TCCG CTCGAGGTCGCGAAGTAACCCTT; U6 3ЈXhoI, 5Ј-TCCGCTCGAGAAAA CGAAATAAATCTCT; ACT1-C256A, 5Ј-ATTTGCTACTGTGTCTCATGTA ATAACATCG; R*⌬U6, 5Ј-TGCGAGATCCGTATGTCGAGAGAT; 3Ј-CUP, 5Ј-CTTCATTTTGGAAGTTAATTAATT; U5B, 5Ј-AAGTTCCAAAAAATAT GGCAAGC; Sen1 OLI2, 5Ј-GGGAGCTAATGGCTCAAGCTGG; and Sen1 20397, 5Ј-TAAACGTTGCAATTAAGG.
RNA analysis. Samples for RNA preparation were harvested from cultures growing at log phase in liquid media at 30ЊC unless otherwise indicated. Selection for the ACT-CUP plasmid was maintained by growth in dropout medium lacking either leucine (for pGAC24 derivatives) or uracil (for pRS426 derivatives), but never under conditions (i.e., in the presence of added copper) that selected for ACT-CUP expression, to eliminate selection for an increased copy number of plasmids containing poorly expressed ACT-CUP genes. Total yeast RNA was prepared by the glass bead-phenol method (63) . Alternatively, some samples were prepared by the guanidinium thiocyanate method (25) . RNA extracted from identical cultures by the two methods gave very similar results, although the second procedure gave a slightly higher recovery of RNA per microgram of nucleic acid (determined by A 260 readings). The first method was adopted for most experiments because of its simplicity.
For primer extension analysis, a procedure based on that of Frank and Guthrie (19) was used. The 3Ј-CUP oligonucleotide used for analysis of ACT-CUP mRNA is complementary to CUP1 sequence just downstream of the ACT-CUP fusion junction and is identical to that used previously (36) . As an internal control, an oligonucleotide (U5B) complementary to the spliceosomal RNA U5 was used. Oligonucleotides were 5Ј end labeled with [␥-32 P]ATP by using T4 polynucleotide kinase and separated from unincorporated label on G25 D-select spin columns (5Ј-3Ј Inc.). Labeled oligonucleotide (50 to 100 fmol) was annealed to 10 g of dried RNA in 6 l of annealing buffer (70 mM NaCl, 50 mM Tris-HCl [pH 8 .0], 10 mM dithiothreitol) by incubating the reaction mixture at 95ЊC for 1 min and 68ЊC for 3 min and then freezing it immediately on dry ice. Samples were slowly thawed, 9 l of extension mix (20 mM NaCl, 17 mM Tris-HCl [pH 8.0], 3.4 mM dithiothreitol, 10.4 mM MgCl 2 ) containing 5 to 10 U of avian myeloblastosis virus reverse transcriptase (United States Biochemical) was added, and reaction mixtures were incubated at 37ЊC for 5 min and then at 42ЊC for 20 min. Formamide sample loading buffer (7.5 l) was then added, and samples were heated to 95ЊC for 3 min before being electrophoresed on 6% polyacrylamide (19:1)-8 M urea sequencing gels. Gels were fixed in 5% methanol-5% acetic acid and dried before exposure to X-Omat AR5 film (Kodak) with an intensifying screen. Gels were also exposed to a phosphor storage screen for quantitation on a Molecular Dynamics PhosphorImager SI using ImageQuant software.
For Northern (RNA) blot analysis, 5 g of total yeast RNA per lane was run on 5% acrylamide (19:1)-8 M urea gels and electroblotted and UV cross-linked onto Zetaprobe membranes (Bio-Rad). Antisense RNA probes were generated by T7 RNA polymerase (United States Biochemical) transcription of a BamHIClaI fragment of the U6R*⌬Nru ACT-CUP construct in pRS426, linearized at the BamHI site, using [␣-
32 P]UTP. The resulting probe is complementary to the 5Ј exon and most of the intron of the U6R*⌬Nru pre-mRNA (see Fig. 3 ). Blots were prehybridized for 1 to 2 h at 65ЊC in a solution containing 0.9 M NaCl, 1% sodium dodecyl sulfate (SDS), 10 mM Tris-HCl (pH 8.0), and 1 mM EDTA and probed in the same solution at 65ЊC overnight. Blots were washed twice in 2ϫ SSC-1% SDS (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate) at 65ЊC and twice in 0.1ϫ SSC-1% SDS at 65ЊC and then exposed to X-ray film and the phosphor screen.
Nucleotide sequence accession number. The GenBank accession number for the sequence presented in this paper is U28487.
in frame to the Cup1 coding region. Cup1 is a copper-chelating protein that is required by yeast for growth in the presence of Cu 2ϩ (26) . When a plasmid-borne ACT1-CUP1 fusion gene is provided in a yeast strain from which the chromosomal CUP1 locus has been deleted, growth of cells on media containing various concentrations of copper is a good indicator of fusion protein expression levels over a broad range and consequently is a sensitive reporter of splicing efficiency as well as other aspects of gene expression (36, 37) .
As part of our studies on the function of the U6 spliceosomal RNA, we introduced the 112-nt sequence of the yeast U6 RNA (7) into the XhoI site in the intron of the ACT1-CUP1 fusion gene (Fig. 1A ) in both orientations. In the forward orientation, the U6 sequence exerted no effect on the expression of the fusion gene, as assessed by growth on copper-containing media (data not shown). However, insertion of the U6 sequence in the reverse orientation (U6R) resulted in moderate sensitivity to copper (no growth at concentrations of Ͼ0.7 mM). A construct containing U6R as well as 5Ј and 3Ј flanking sequences (generated fortuitously during cloning) at both ends of the U6 sequence (U6R*; see Materials and Methods) resulted in severe sensitivity to copper at concentrations of Ͼ0.15 mM and a 20-fold decrease in the ACT-CUP mRNA level (Fig. 1A) .
The U6R* insertion differs from the precise U6R insertion in the presence of 5Ј and 3Ј flanking sequences of 33 and 34 nt in length, respectively. Since U6R results in only modest copper sensitivity, one or both of the flanking sequences must be required for the expression defect of U6R*. To identify the minimum required flanking sequences, the effect of partial deletions of the U6R* element on copper sensitivity and ACT-CUP mRNA level was determined. Deletion of the 3Ј flanking sequence (yielding U6R*⌬Nru) did not relieve copper sensitivity or the RNA accumulation defect (Fig. 1A) , indicating that the 5Ј flanking sequence in combination with antisense U6 is sufficient. The 5Ј flanking sequence contains two overlapping copies of a 16-nt sequence. Deletion of one of the repeats (yielding U6R*⌬13) did not alleviate the RNA accumulation defect (Fig. 1A) ; thus, only a single copy is required for the full effect on expression. In the absence of antisense U6 (R*⌬U6), the 5Ј flanking sequence did not significantly inhibit ACT-CUP expression, and thus it is not sufficient for the effect.
A 14-nt region of the antisense U6 RNA sequence required for the expression defect is defined by spontaneous cis suppressor point mutations (Fig. 1B ) (see below). To determine if other regions of the antisense U6 sequence are also required, we deleted 67 nt of antisense U6 distal to the cis suppressor region. This deletion (U6R*⌬NE) restores mRNA expression to 60% of the wild-type level (Fig. 1A) , indicating that important features are contained in the distal portion of antisense U6. This region appears to contain redundant features, since inclusion of either 5Ј or 3Ј portions of the 67 nt resulted in restoration of much of the expression defect (data not shown).
cis suppressor mutations define a central sequence-specific portion of the element. Although the U6R* insertion in the ACT1-CUP1 fusion gene intron prevents growth on plates containing Ͼ0.15 mM copper, exceptional colonies resistant to copper concentrations of 0.4 mM or higher arise spontaneously at a frequency of ϳ10
Ϫ7
. We have analyzed approximately 30 of these copper-resistant revertants. Seventeen contained plasmid-linked suppressor mutations allowing increased expression of the fusion gene, since recovery of their ACT-CUP plasmids and transformation into the parental strain resulted in copper-resistant growth. Sequencing of the ACT-CUP intron in each of these plasmids revealed that the cis-acting suppressor mutations fall into two categories: (i) complete deletion of the reverse U6 sequence, facilitated by direct repeats of 14 bp present in the 5Ј and 3Ј flanking sequences of U6R* (six independent isolates); and (ii) 10 single point mutants and 1 double point mutant clustered in a 14-nt region near the 5Ј end of the reverse U6 sequence (Fig. 1B) . One of these mutations (A90ЈG) was recovered four times independently. For all four of the point mutations tested, primer extension analysis of RNA revealed significantly increased levels of the spliced ACT-CUP mRNA (data not shown).
To test whether the point mutant suppressors act by disrupting complementarity to U6 RNA, individual point mutations complementary to one of two suppressor mutations (A90ЈG or G92ЈU) were introduced into the U6 gene (yielding U6-U90C or U6-C92A). Both mutations in U6 RNA were found to be viable, but neither suppressed the accumulation defect of U6R* pre-mRNA (data not shown). Furthermore, the sup- 2 ) and presented as the ratio of mRNA to U5 RNA, normalized to the wild-type ACT-CUP fusion (no insert). (B) The sequence of the 14-nt region of antisense U6 defined by cis suppressor point mutations. Arrows indicate the seven single point mutant suppressors and one double point mutant (boxed). The A90ЈG mutation that was recovered independently four times is underlined. Numbering is relative to the 5Ј end of sense U6 RNA; for example, nt 1Ј is complementary to nt 1 of U6 RNA.
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on January 18, 2018 by guest http://mcb.asm.org/ pression afforded by the cis mutation, A90ЈG, was not reverted by the complementary mutation, U90C, in U6 RNA. The failure of the U90C and C92A mutations in U6 RNA to act as trans suppressors allows us to conclude that the complementary nucleotides in antisense U6 are not important because of their complementarity to U6 per se. The U6R* element causes decreased accumulation of premRNA. To examine whether decreased expression of the ACT-CUP fusion protein from the insertion constructs is due to inhibition of splicing, we determined the steady-state ratio of mature spliced ACT-CUP mRNA (M) to unspliced premRNA (P) by primer extension with a second-exon probe (Fig.  2) . Changes in splicing efficiency are most accurately represented by changes in the M/P ratio, while any influence of mutations on pre-mRNA stability is reflected proportionally in both the mature and precursor RNA pools (47) .
The wild-type actin intron in the ACT-CUP fusion is spliced very efficiently, with abundant spliced mRNA and very little accumulation of pre-mRNA ( Fig. 2A, lane 1) . Primer extension of RNA from the U6R insertion construct shows somewhat reduced levels of spliced mRNA, as well as a faint novel doublet of intermediate mobility (lane 3). Northern blot analysis (see below) shows that full-length pre-mRNA and spliced mRNA are the only major ACT-CUP products in this RNA preparation, suggesting that the truncated cDNA products are derived from full-length pre-mRNA as the result of premature reverse transcriptase stops. The size of the aberrant cDNAs is consistent with reverse transcriptase stops near the 3Ј end of the antisense U6 sequence, suggesting that extension to the 5Ј end of the pre-mRNA may be prevented by hybridization of the antisense U6 sequence to U6 RNA present in the preparation. This was confirmed by adding a cocktail of oligonucleotides complementary to U6 RNA to prevent its base pairing to antisense U6 during the annealing step of the primer extension assay, which increased the yield of cDNA extended to the 5Ј end of the pre-mRNA (data not shown). Using these truncated products as well as the small amount of full-length cDNA product to represent the abundance of full-length pre-mRNA, quantitation of the M/P ratio revealed that splicing of the U6R intron is inhibited seven-to eightfold compared with that of the wild-type intron, although the steady-state level of mature mRNA is decreased only approximately twofold (Fig. 2B) .
Also shown in Fig. 2 are the results of analysis of RNA from the U6R*⌬Nru construct. The most striking result is the very low abundance of both spliced mRNA and unspliced U6R*⌬Nru precursor (lane 5). As with the U6R RNA, primer extension of the full-length pre-mRNA appears to be blocked, resulting in truncated cDNA products (visible on longer exposure). Quantitation of the low levels of mRNA and pre-mRNA represented by the primer extension products indicates that they occur in the same ratio as in the U6R RNA sample, although the steady-state level of mature mRNA is 20-fold less than is produced from the wild-type pre-mRNA and 10-fold less than is produced from the U6R pre-mRNA (Fig. 2B) . Thus, in addition to the splicing defect seen with the precise antisense U6 sequence, the U6R*⌬Nru insert inhibits the accumulation of both mRNA and pre-mRNA.
To examine the pre-mRNA accumulation deficit independently of the splicing inhibition phenotype, we introduced a mutation in the intron branch point sequence (UAAUAAC, or C256A) that strongly inhibits splicing of the actin intron, leading to the accumulation of pre-mRNA (46, 65) . Quantitation of pre-mRNA levels by primer extension showed that the U6R/ C256A pre-mRNA (Fig. 2A, lane 4) accumulates to approximately 70% of the level of wild-type ACT-CUP/C256A premRNA (lane 2), but the U6R*⌬Nru/C256A pre-mRNA (lane 6) accumulates to only about 5% of the level of wild type/ C256A or 7% of that of U6R/C256A pre-mRNA (Fig. 2B) . This indicates that a severe defect in expression of the U6R* constructs occurs at the level of pre-mRNA accumulation, independently of the catalysis of splicing.
Appearance of 3-truncated pre-mRNA products coincides with the accumulation defect. The decreased accumulation of the U6R*-containing pre-mRNA could result from a block in transcript initiation or elongation or from enhancement of posttranscriptional turnover of pre-mRNA. The primer extension analysis presented above employed a single oligonucleotide probe complementary to sequences in the 3Ј exon and thus was not well suited for the detection of products of stalled transcription or possible degradation intermediates. To test for the presence of such products, Northern blot analysis was performed with a probe complementary to the 5Ј exon and 
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on January 18, 2018 by guest http://mcb.asm.org/ most of the intron of the U6R*⌬Nru pre-mRNA (Fig. 3A) . Several discrete minor products were detected in samples of total RNA from either the U6R*⌬Nru or U6R*⌬Nru/C256A constructs, but not in samples from the wild-type ACT-CUP or U6R constructs or their C256A derivatives (Fig. 3B) . These RNA fragments are derived from the 5Ј portion of the gene, since they were also detected with a smaller probe complementary to only exon 1 and the 5Ј portion of the intron (data not shown), and must include intron sequences, since identical products are present in samples from the wild-type and mutant branch point samples. Assuming that these RNA molecules retain intact 5Ј ends, the size of the smallest of these fragments (approximately 320 nt) places its 3Ј end very close to the 3Ј junction of the U6R*⌬Nru insertion with intronic sequences. This coincides with a potential RNA hairpin that can form in the antisense U6 sequence, which may form a barrier to 3Ј-5Ј exonucleolytic digestion or may be a determinant of transcriptional elongation arrest (see Discussion). The doublet of more slowly migrating species at 350 to 360 nt corresponds to 3Ј ends occurring within the intron sequence, about 30 to 40 nt downstream of the insertion site, and does not correspond to any obvious RNA secondary structure, but it may fall within a long pyrimidine-rich stretch containing several runs of U residues.
Genomic loci involved in U6R*-dependent control of premRNA accumulation. In addition to the cis-acting suppressor mutations described above, several spontaneously arising mutations unlinked to the ACT-CUP plasmid allowed growth of the U6R*-containing strain on media with copper concentrations of Ͼ0.4 mM. Preliminary analysis of RNA from several of these putative trans suppressor strains revealed the presence of increased levels of both mature ACT-CUP mRNA and premRNA. We chose one of these suppressor strains, which had a tight temperature-sensitive growth defect that was recessive in a backcross to an otherwise isogenic strain, for more detailed study. Upon sporulation of this heterozygous diploid, the temperature sensitivity and suppression phenotypes cosegregated as a single Mendelian determinant in each of 13 tetrads analyzed, indicating tight linkage of the two phenotypes.
A haploid MATa strain derived from this backcross that C256A branch point mutation in an otherwise wild-type ACT-CUP fusion; lane 6, C256A mutation in the U6R construct; lane 7, C256A mutation in the U6R*⌬Nru construct. The probe hybridizes more efficiently to pre-mRNA than to mRNA, as judged by comparison to primer extension results (Fig. 2) .
FIG. 4.
The nrd1-1 and nrd2-1 mutations relieve the pre-mRNA accumulation defect and prevent the generation of truncated products from the U6R*-containing pre-mRNA. (A) Primer extension analysis of wild-type ACT-CUP, U6R, and U6R*⌬Nru/C256A mRNA and pre-mRNA in NRD ϩ , nrd1-1, and nrd2-1 strains at the permissive temperature (23ЊC). Lanes 1 to 3, RNA from strains containing the wild-type ACT-CUP fusion; lanes 4 to 6, RNA from strains containing the U6R insertion in the ACT-CUP fusion; lanes 7 to 9, RNA from strains containing the U6R*⌬Nru insertion in the ACT-CUP fusion gene that also contains the C256A branch point sequence mutation. Lanes 1, 4, and 7, NRD ϩ parent strain (46␣); lanes 2, 5, and 8; nrd1-1 strain; lanes 3, 6, and 9, nrd2-1 strain. Positions of primer extension products and the U5 RNA primer extension control are indicated. Symbols are defined in the legend to on January 18, 2018 by guest http://mcb.asm.org/ contained the suppressor mutation causing temperature sensitivity was then used in genetic complementation tests against a series of MAT␣ suppressor strains that also had temperaturesensitive phenotypes scoring as recessive or partially recessive in the parental backcross. These crosses defined two complementation groups, one represented by six independent alleles and a second defined by a single suppressor mutation. We have designated these complementation groups nrd1 and nrd2, respectively (for nuclear pre-mRNA down-regulation).
To allow quantitation of U6R* pre-mRNA levels in these strains without the additional complication of possible effects on splicing efficiency, we again used the C256A branch point mutation in the context of the U6R*⌬Nru construct. Primer extension analysis of RNA from the nrd1-1 and nrd2-1 suppressor strains showed 30-and 10-fold-increased abundance of U6R*⌬Nru/C256A pre-mRNA relative to the parent strain, respectively (Fig. 4A, lanes 7 to 9) . However, mRNA levels and pre-mRNA/mRNA ratios produced from the wild-type ACT-CUP fusion (lanes 1 to 3) and from the U6R construct (lanes 4 to 6) are indistinguishable in the nrd1-1, nrd2-1, and wildtype parent strains. Thus, the trans suppressor mutations specifically relieve the pre-mRNA accumulation defect due to the U6R* insertion but not the moderate splicing defect due to the precise U6R insertion. Furthermore, nrd1-1 and nrd2-1 do not act as general enhancers of ACT-CUP fusion gene expression.
We next examined the RNA products of the U6R*⌬Nru/ C256A construct in the nrd1-1 and nrd2-1 strains by Northern blot analysis. As shown in Fig. 4B , both mutant strains prevent the accumulation of truncated fragments and greatly increase the accumulation of full-length pre-mRNA in comparison to the wild-type parent. This strongly suggests that the underexpression of full-length pre-mRNA and the accumulation of truncated transcripts are causally related.
NRD1 encodes a novel hnRNP-like protein. We cloned the NRD1 gene by complementation of the temperature sensitivity of the nrd1-1 strain by using a YCp50-based yeast genomic library (52) . Two independent transformants selected at 37ЊC contained apparently identical complementing plasmids with an insert of approximately 10 kb. Deletion analysis localized the complementing gene to a 4.8-kb HindIII-SalI fragment, and an internal EcoRI site further divides this fragment into a weakly complementing 2.7-kb HindIII-EcoRI fragment and a noncomplementing EcoRI-SalI fragment (see Fig. 6A ). DNA sequencing revealed a single large open reading frame (ORF) between the HindIII and EcoRI sites, ending just downstream from the EcoRI site and encoding a predicted polypeptide of 575 amino acids (Fig. 5A) . The sequence upstream of the ORF overlaps with the reported sequence of a clone containing the RAD50 gene (1) and thus localizes the cloned DNA to the left arm of chromosome XIV, with the newly identified ORF and the RAD50 gene divergently transcribed and their coding regions separated by 1.1 kbp. That this ORF represents the NRD1 gene was confirmed by the identification of mutations in several independently selected, spontaneously arising nrd1 mutant strains (see below).
The sequence of the predicted Nrd1 protein contains several features relevant to its potential role in pre-mRNA metabolism (Fig. 5) . The region between residues 340 and 410 contains sequence matching the RNA recognition motif (RRM), or a ribonucleoprotein consensus sequence derived from a large number of RNA-binding proteins (5, 8, 29) . The RNP2 hexamer of Nrd1, LFIGGV (residues 341 to 346), is very similar to those of mammalian hnRNP A, B, and G proteins. The RNP1 octamer, RKHAFVKV (residues 374 to 381), is more atypical, particularly in the presence of the lysine at the second position of the octamer, shared only with RRM 1 of nucleolins, and the histidine residue at position 3, unique among reported RRM protein sequences.
Another segment of Nrd1 with potential for a role in premRNA metabolism is the region between residues 245 and 265, which contains a high density of arginine, serine, and glutamate residues, with arginine often alternating with glutamate or serine (RE/RS). Similar but often more extensive RS or RE/RS domains occur in a number of metazoan RRMcontaining splicing factors, including members of the SR protein family and related proteins (6, 21) .
The C-terminal 75 residues of Nrd1 are rich in glutamine (Q) and proline (P) residues (25 and 21%, respectively), including a stretch of 8 consecutive Q residues just prior to the C-terminal residue. Several yeast hnRNP-like proteins, including Nab1, Nab2, and Nab3, contain similar P-and Q-rich domains (66) . The Nrd1 PϩQ domain is most similar in amino acid composition and in its carboxy-terminal location to that found in Nab3. Similar P-and Q-rich domains are also found in a number of metazoan RRM proteins, including the Drosophila elav (51) and the mammalian TIA-1 (62) proteins. In none of these cases has a function been ascribed to the P-and Q-rich segment.
The amino-terminal 140 residues of Nrd1 exhibit similarity to the amino-terminal domain of a recently identified mammalian SR-like protein called rA8 (68) . This domain of rA8 and the corresponding region of Nrd1 have been shown to bind to the C-terminal domain (CTD) of the largest subunit of mouse RNA polymerase II in a yeast two-hybrid assay (68) . In addition to sequence similarity in the N-terminal domain, rA8 has a domain organization similar to that of Nrd1, with an RE/RS dipeptide-rich region and a single RRM domain as well as several proline and/or glutamine-rich segments (Fig. 5C) . Shown in Fig. 5D is the alignment of the N-terminal CTDbinding domains of Nrd1 and rA8, along with N-terminal domains of putative gene products from S. cerevisiae, Schizosaccharomyces pombe, and Caenorhabditis elegans identified in BLAST searches. Apart from their N termini, the last three proteins have a domain organization that differs from that of the Nrd1 and rA8 proteins but are highly related to each other through much of their lengths, including potential Zn 2ϩ finger motifs. The function of the rA8 protein is not known, but it and related mammalian proteins have been proposed to couple transcription with pre-mRNA splicing (68) .
Disruption of NRD1 is lethal. To determine if NRD1 is essential for growth, the gene was disrupted by substitution of a DNA fragment containing the HIS3 gene for all but the N-terminal 38 codons of the NRD1 coding region (Fig. 6A) . A diploid strain heterozygous for the chromosomal disruption of NRD1 was created by one-step gene disruption (53) , and integration of the nrd1⌬::HIS3 allele into the NRD1 locus was confirmed by Southern blot analysis (data not shown). Sporulation of this strain gave rise to tetrads that segregated 2:0 for viability (Fig. 6B) , with no viable HIS ϩ spores recovered from dissection of 42 tetrads, suggesting that disruption of NRD1 is lethal. Upon microscopic examination, many of the nonviable spores were found to undergo germination and several rounds of cell division before ceasing to grow.
To demonstrate that the disruption could be complemented by the cloned Nrd1 gene, the diploid strain heterozygous for the nrd1⌬::HIS3 disruption was sporulated after introduction of NRD1 on a plasmid marked with the URA3 gene. HIS ϩ URA ϩ progeny but no HIS ϩ ura Ϫ progeny were recovered from this dissection, whereas both his Ϫ ura Ϫ and his Ϫ URA ϩ progeny were recovered. The resultant strains were tested for dependence on the plasmid-borne NRD1 gene by plating them on medium containing 5-FOA to select for loss of the URA3- To identify the NRD1 mutations responsible for temperature sensitivity and suppression of the pre-mRNA accumulation defect, the nrd1-1, -2, -3, and -5 alleles were isolated by gap repair (53) . Mutations were identified by sequencing and are summarized in Fig. 7 . The nrd1-1, -2, and -3 alleles each contain a single point mutation that creates a premature stop codon early in the coding region, such that their predicted products lack the RRM and PϩQ domains. The truncated proteins encoded by nrd1-1 and nrd1-3 additionally lack the RE/RS domain. The nrd1-5 allele results in the substitution of a glycine residue for valine at residue 368, within the RRM, at a site predicted to fall within ␤-strand 2 of the RRM structure based on alignment with RRM domains whose structures have been determined (42) . The nrd1-3 strain, although temperature sensitive, is viable at 18 to 30ЊC, suggesting that the Nterminal 163 amino acids of Nrd1 are sufficient for viability of yeast cells. However, a function(s) mediated by at least the RRM domain is clearly required for the U6R*-dependent premRNA accumulation defect.
NRD2 is identical to SEN1, a putative helicase. The NRD2 gene was cloned by complementation of the temperature sensitivity of the nrd2-1 strain with the yeast genomic library. Five independent complementing clones were recovered from ϳ50,000 transformants of the nrd2-1 strain. Preliminary restriction and sequence analyses revealed that the clones fall into two related classes containing overlapping fragments of chromosome XII. The 13.3-kb overlap shared by the two clone types contains three potential ORFs, one of which encodes Sen1 (15) . Deletion of SEN1 resulted in loss of complementation activity, and a clone containing only the Sen1 ORF was able to complement the temperature sensitivity of nrd2-1, suggesting that the nrd2-1 mutation is in the SEN1 gene.
Sen1 is an essential nuclear protein (15, 64) . Although it is 2,231 amino acids in length, a previous study demonstrated that the carboxy-terminal 1,214 residues, containing a putative ATP-dependent helicase domain, are sufficient for viability (15) . The similarity of the Sen1 helicase domain to that in the yeast Upf1 protein, which is involved in nonsense-mediated mRNA decay, and to a mouse protein, Mov-10, of unknown function has been noted previously (31, 34) . Upf1 was recently demonstrated to have ATP-dependent helicase activity in vitro (11) . The BLAST program (2) identifies a number of additional putative helicases from S. cerevisiae, S. pombe, C. elegans, and mammals which have a high degree of similarity to this domain of Sen1.
The chromosomal nrd2-1 allele was isolated by gap repair (53) . Sequencing of approximately 1.2 kb in the helicase domain identified a point mutation converting codon 1597 (1478 in reference 15) from GAA (coding for glutamate) to AAA (coding for lysine) (Fig. 8 ). This mutation, E1597K, alters a glutamate residue that is conserved in Upf1, Mov-10, and many of the other related putative helicases. It is located 7 residues C terminal to an aspartate residue (marked by an asterisk in Fig. 8 ) that is widely conserved among ATPases and ATP-dependent helicases (23, 27, 31) and has been implicated in positioning a Mg 2ϩ ion thought to be involved in ATP hydrolysis (20, 60) . The nrd2-1 mutation thus is likely to affect the putative ATPase activity and helicase function of Sen1.
To demonstrate that the E1597K mutation is solely responsible for the temperature sensitivity and suppression phenotypes of the nrd2-1 strain, linear DNA fragments encompassing codons 1457 to 1696 were generated by PCR amplification of the SEN1 wild-type or nrd2-1 mutant clones. These DNAs were used to transform the nrd2-1 strain, and temperatureresistant revertants were selected at 37ЊC. Transformation with the PCR product from the wild-type clone yielded temperature-resistant revertant colonies that showed coreversion of the copper resistance phenotype. Transformation with the nrd2-1 mutant PCR product failed to yield temperature-resistant revertants. We conclude that the E1597K mutation in Sen1 is responsible for both the temperature sensitivity and the suppression of the U6R*-dependent pre-mRNA accumulation defect.
DISCUSSION
A novel nuclear pathway for repression of gene expression in S. cerevisiae. We have identified an exogenous sequence element that causes underaccumulation of a reporter premRNA when inserted into its intron and have defined two trans-acting factors that participate in this process. One of these factors, Nrd1, is a novel yeast hnRNP-like protein, and on January 18, 2018 by guest http://mcb.asm.org/ the second, Sen1, is a previously identified nuclear protein with putative helicase activity. Several observations indicate that control of pre-mRNA accumulation via this pathway occurs in the nucleus at a stage subsequent to the initiation of transcription but prior to splicing: (i) the cis element functions within an intron, more than 170 nt downstream of the transcription initiation site; (ii) Nrd1 contains a consensus RRM and other auxiliary domains similar to those found in a number of hnRNP proteins; and (iii) underexpression of cis-element-containing pre-mRNA is accompanied by the appearance of 3Ј-truncated pre-mRNA fragments containing partial intron sequences. Furthermore, the underexpression of pre-mRNA is independent of the cytoplasmic nonsense-mediated mRNA decay pathway (59a). We hypothesize that Nrd1 binds via its RRM to the U6R* element in the nascent pre-mRNA and that this binding is a key step in specifying the pre-mRNA for down-regulation. The 14-nt sequence-specific subelement defined by cis suppressor mutations is an excellent candidate target site for recognition by Nrd1. Considering that pre-mRNA splicing is likely to occur cotranscriptionally, the problem of recognizing an intronic sequence element before it is spliced out implies that Nrd1 associates with its target site very soon after that site is synthesized. This suggests that Nrd1 may be associated with the transcription apparatus. It is therefore intriguing that a recently identified mammalian homolog of Nrd1 interacts with the repetitive CTD of the largest subunit of mouse RNA polymerase II in a two-hybrid screen (68) . Indeed, the putative CTD-binding domain of Nrd1 also interacts with the mouse CTD in the two-hybrid assay, albeit weakly (68) . Importantly, the mouse CTD can functionally replace the yeast CTD and so must be capable of mediating interactions essential for CTD functions in S. cerevisiae (68) . It will be interesting to determine if the mammalian Nrd1 homolog can function in yeast cells.
Mutations in Sen1 affect a variety of essential nuclear functions. The sen1-1 mutation, first identified in a screen for mutants defective in pre-tRNA splicing (15) , was subsequently found to result additionally in mislocalization of the nucleolar proteins Ssb1 and Nop1 and in pre-rRNA processing defects (64) . A SEN1 allele (named cik3-1) has also been identified in a screen for mutations that cause chromosomal instability and defects in nuclear fusion (45, 64) . Results presented here represent the first evidence of a role for the putative helicase activity of Sen1 in pre-mRNA metabolism. The involvement of Sen1 in Nrd1-dependent control of pre-mRNA accumulation provides further evidence that this pathway is localized to the nucleus.
Potential mechanisms for repression of pre-mRNA accumulation by the Nrd pathway. Physical association of Nrd1 with the CTD of RNA polymerase II could provide a mechanism for controlling pre-mRNA accumulation at the level of transcript elongation. Transcription of several proto-oncogenes is regulated at the level of elongation (59) , and the importance of such control is further underscored by the recent finding that the product of the von Hippel-Lindau tumor suppressor gene negatively controls the elongation-enhancing activity of an RNA polymerase II auxiliary factor known as SIII or elongin (17, 30) . Perhaps the specificity of elongation control in eukaryotes is endowed in part by factors like Nrd1, just as RNAbinding factors regulate elongation in E. coli (14, 24, 49) . Interaction of Nrd1 with the CTD, and any consequent effects on transcript elongation, may be modulated by the phosphorylation state of the CTD, which is correlated with the elongation properties of the polymerase (12) .
A number of parallels exist between our observations and the paradigm of rho-dependent termination in E. coli (for a review, see reference 49). Rho factor is an RNA-dependent ATPase and helicase that is activated by specific elements in nascent RNA. As a consequence of rho's action, RNA polymerase terminates transcription at sites downstream of rho's initial binding site. Perhaps the pre-mRNA fragments generated in response to the U6R* element are produced by a similar mechanism, given the involvement of the putative RNA-binding factor Nrd1 and the putative helicase Sen1.
Alternatively, binding to the CTD may serve simply to localize Nrd1 in the vicinity of the nascent transcript and may not directly control transcript elongation activity per se. In this case, truncation of U6R*-containing pre-mRNA may occur instead through recruitment of a degradative pathway. The similarity of Sen1 to Upf1, which participates in nonsensemediated mRNA degradation (34) , suggests the possibility that a nuclear pre-mRNA surveillance system responsible for degradation of abnormal transcripts is recruited by the U6R* element. Distinction between mechanisms invoking control of transcript elongation and those involving pre-mRNA degradation may prove difficult to establish experimentally. Indeed, transcription termination may actually be coupled to endonucleolytic cleavage of the transcript (54) .
Cellular functions of Nrd1. Disruption of the NRD1 gene is lethal to yeast cells. Our characterization of spontaneously arising mutant alleles of NRD1 suggests that the N-terminal 163 amino acid residues of the protein, roughly coinciding with the N-terminal CTD-binding domain (68) , are sufficient for viability except at elevated temperatures. Thus, the essential role of Nrd1 may be as an auxiliary factor for RNA polymerase II. However, cis-element-dependent control of pre-mRNA accumulation requires functions mediated by the remainder of Nrd1 and, in particular, by the putative RNA binding domain. Mutant alleles of Nrd1 containing premature stop codons or a missense mutation in the RRM decouple the function of the N-terminal domain of Nrd1 from the pre-mRNA effector function. Posttranslational modifications of Nrd1, such as phos- FIG. 8 . The nrd2-1 mutation alters a conserved residue near the predicted ATP hydrolysis site of Sen1. A linear diagram of the Sen1 protein is presented, with the nonessential N-terminal portion and the putative helicase domain indicated. The expanded region shows the sequences of Sen1, Upf1, and Mov-10 in the region of the nrd2-1 mutation (E1597K). Residues in Upf1 and Mov-10 that are identical to those in Sen1 are boxed. The asterisk identifies an aspartate residue that is highly conserved among ATPases and helicases and is thought to participate in ATP binding and hydrolysis by positioning a Mg 2ϩ ion that is coordinated to the ␤ and ␥ phosphates of ATP (20, 60) . The numbering of Sen1 amino acids corresponds to the ORF predicted by the sequence of chromosome XII as determined by systematic sequencing of the yeast genome (GenBank accession number 20939). This sequence differs from that previously reported (15) by the inclusion of an additional A residue in codon 130 of the current numbering system, shifting the frame of the Sen1 ORF such that the N-terminal 11 residues of the sequence of DeMarini et al. (15) are replaced by an additional 130 residues.
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on January 18, 2018 by guest http://mcb.asm.org/ phorylation, may similarly decouple these functions, potentially providing a mechanism for regulation of gene expression in response to environmental stimuli. Given the sequence specificity and the efficiency of Nrd1-dependent control of pre-mRNA accumulation, it seems likely that this pathway is exploited by the cell to control gene expression. However, we cannot rule out the possibility that the response is idiosyncratic to the artificial combination of sequences created by the insertion of the U6R* element into the particular reporter gene system we have used. Further study will be needed to identify natural targets of this potential control mechanism. The precise sequence of the 14-nt region identified by suppressor point mutations occurs only once in the yeast genome, on the nontranscribed strand of the U6 RNA gene, SNR6. More than 300 genomic sequences match the eight positions at which spontaneous suppressor mutations have been identified, and these genomic sequences occur in noncoding regions as well as on either strand in coding regions. Furthermore, although the 8 nt are clearly important for Nrd1-dependent pre-mRNA underexpression, they are not sufficient. Our studies demonstrate additional requirements for upstream and downstream sequences whose relevant features remain unclear. Therefore, genomic sequence analysis is of limited value in identifying natural targets of the Nrd1 pathway.
Mammalian CTD-binding proteins related to Nrd1 have been proposed to facilitate pre-mRNA splicing, based on the fact that they contain extensive RE/RS domains similar to those found in many metazoan splicing factors and the observation that the CTD may play an important role in splicing in vitro (68) . According to this view, the CTD may act as an assembly platform for splicing components. The similar domain organization shared by Nrd1 and these mammalian proteins suggests that they may play similar roles. However, the nrd1-1 allele has no detectable effect on splicing of ACT-CUP (Fig. 4) or CYH2 (59a) pre-mRNAs under conditions in which the U6R*-dependent pre-mRNA accumulation defect is fully suppressed. Given that this and other viable mutant alleles of Nrd1 are predicted to lack the RE/RS and RRM domains, any Nrd1-mediated role in yeast pre-mRNA splicing may be nonessential or redundant.
Our results provide a unique glimpse into the critical period in pre-mRNA metabolism occurring after transcript initiation and before splicing and suggest the existence of a novel mechanism by which gene expression can be stringently controlled during this stage. A key player in this pathway, the Nrd1 protein, is related to recently identified mammalian proteins, suggesting that this control mechanism may also be conserved. The genetic approach we have initiated holds promise for further characterization of the Nrd pathway for pre-mRNA control.
